DIGITAL.CSIC. Repositorio Institucional del CSIC
Publicación
Artículo científico (JournalArticle)
Defective Olfactomedin-2 connects adipocyte dysfunction to obesity
Olfactomedin-2 (OLFM2) is a pleiotropic glycoprotein emerging as a regulator of energy homeostasis. We here show the expression of OLFM2 to be adipocyte-specific and inversely associated with obesity. OLFM2 levels increase during adipogenesis and are suppressed in inflamed adipocytes. Functionally, OLFM2 deficiency impairs adipocyte differentiation, while its over-production enhances the adipogenic transformation of fat cell progenitors. Loss and gain of function experiments revealed that OLFM2 modulates key metabolic and structural pathways, including PPAR signaling, citrate cycle, fatty acid degradation, axon guidance and focal adhesion in 3T3 cell lines and primary human adipocytes. On the molecular level, OLFM2 deficiency in differentiated adipocytes predominantly downregulates genes involved in cell cycle. Extending these findings in vivo, both whole-body Olfm2 knockout and adipose-specific Olfm2 depletion in mice resulted in impaired adipose cell cycle gene expression, with the latter also displaying fat mass accretion and metabolic dysfunction. Collectively, our results underscore a critical role for OLFM2 in adipocyte biology, and support a causative link between reduced adipose OLFM2 and the pathophysiology of obesity., This study has been funded by the Instituto de Salud Carlos III (ISCIII), through the projects CP19/00109, PI18/00550, and PI21/00074 (to F.J.O.), the Ministerio de Ciencia e Innovación (PID2022-141115NA-I00 to I.G.-G.; PID2022-142951OB-I00 to S.M.; PID2021-128145NB-I00 and PDC2022-133958-I00, to M.L.), and the Xunta de Galicia (ED431C 2024/10 and ED431F 2024/14, to I.G.-G.), also co-founded by the European Union and the Fondo Europeo de Desarrollo Regional (FEDER). F.J.O. (MS19/00109) is recipient of the Miguel Servet scheme (ISCIII), A.L. (FI19/00045) is recipient of a Contrato Predoctoral de Formación en Investigación en Salud (PFIS, ISCIII), I.G.-G. is supported by a Ramón y Cajal award (RYC2021-031225-I), and N.F.M. is recipient of a Contrato Predoctoral para la Formación de Doctores (PREP2022-000775), Ministerio de Ciencia, Innovación y Universidades, Gobierno de España (ES). N.N. and S.I.T. were supported by the Intramural Research Programs of the National Eye Institute, NIH. The authors thank the CERCA and PERIS programmes (Generalitat de Catalunya) for financial and institutional support, and are indebted to the participants of the FATBANK platform, promoted by the Centro de Investigación Biomédica en Red de la Fisiopatología de la Obesidad y la Nutrición (CIBEROBN, ISCIII) and the Institut d’Investigació Biomèdica de Girona (IDIBGI) Biobank (Biobanc IDIBGI, B.0000872), integrated in the Spanish National Biobanks Network, for their collaboration and coordination. We would like to thank the Animal Facility of the Barcelona Science Park and its staff for the technical assistance provided in carrying out the tasks related to the work with animals. The authors are also indebted to the IMIM Microarray Analysis Service (Hospital del Mar Medical Research Institute, Barcelona, Spain) for technical guidance., Peer reviewed
Proyecto:
AEI PID2022-141115NA-I00
,
AEI PID2022-142951OB-I00
,
AEI PID2021-128145NB-I00
,
AEI PDC2022-133958-I00
,
AEI RYC2021-031225-I
,
AEI PREP2022-000775
DOI: http://hdl.handle.net/10261/402787, https://api.elsevier.com/content/abstract/scopus_id/105012626154
HANDLE: http://hdl.handle.net/10261/402787, https://api.elsevier.com/content/abstract/scopus_id/105012626154